Support your neighborhood scientist

By KIM BELLARD These are, it must be said, grim times for American science. Between the Trump budget cuts, the Trump attacks on leading research universities, and the normalization of misinformation/ disinformation, scientists are losing their jobs, fleeing to other countries, or just trying to keep their heads down in hopes of being able to…

Read More

Links

Measles outbreak expands to 19 states.Commercial health plan coverage of accelerated approval drugs…and a recent case study.Extending IRA drug price negotiation to commercial plans?‘Kennedy Turns to a Discredited Vaccine Skeptic for Autism Study’Why are LLMs so good at economics?Most expensive states to start a business.

Read More

Cost-effectiveness analysis model for sotagliflozin compared with insulin monotherapy for patients with type 1 diabetes and chronic kidney disease

That is the title of my latest paper in JMCP with co-authors Jaehong Kim, Shanshan Wang, Moises Marin, Slaven Sikirica, and Mariam Anderson. The study abstract is below. BACKGROUND: Patients with type 1 diabetes (T1D) have a greater than 50% lifetime risk of developing comorbid chronic kidney disease (CKD). Glycemic control can reduce diabetes-related complications…

Read More